What is the future of genito-urinary cancers clinical research?

EORTC
Europe/London GMT+1

Description

Programme

 

12:30-12:35 Brief introduction on genito-urinary cancers clinical trials – Prof. Bertrand Tombal

12:35-12:50 Testis cancer: IGCCCC (International Germ Cell Consensus Classification)-update (supported by Movember) – Prof. Silke Gillessen

12:50-13:00 Questions of RCT (Randomized Clinical Trial) versus registry, why we need both and can’t anymore rely on one – Prof. Bertrand Tombal

13:00-13:15 How AI (Artificial Intelligence) applied to imaging may support clinical trials in Oncology? – Prof. Luc Bidaut

13:15-13:30 Q&A session moderated by Prof. Bertrand Tombal

Bertrand Tombal

Brief introduction on genito-urinary cancers clinical trials, Testis cancer: IGCCCC (International Germ Cell Consensus Classification)-update (supported by Movember), Questions of RCT (Randomized Clinical Trial) versus registry, why we need both and can’t anymore rely on one, How AI (Artificial Intelligence) applied to imaging may support clinical trials in Oncology?, Q&A session

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Silke Gillessen, Luc Bidaut

 

Link to the Event

Banner to the Event

What is the future of genito-urinary cancers clinical research?
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2020 "24 years inspiring technology"